EWTX Company Profile and Key Details
Edgewise Therapeutics, Inc.
EWTX Stock Price Chart
Stock Price Today
Edgewise Therapeutics, Inc. (EWTX) stock declined over -0.91%, trading at $27.14 on NASDAQ, down from the previous close of $27.39. The stock opened at $26.06, fluctuating between $26.00 and $27.46 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Company Information
| Employees | 108 |
| Beta | 0.15 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stock price is $27.14 in the last trading session. During the trading session, EWTX stock reached the peak price of $27.46 while $26.00 was the lowest point it dropped to. The percentage change in EWTX stock occurred in the recent session was -0.91% while the dollar amount for the price change in EWTX stock was -$0.25.
The NASDAQ listed EWTX is part of Biotechnology industry that operates in the broader Healthcare sector. Edgewise Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. R. Michael Carruthers
Chief Financial Officer
Mr. John R. Moore
Gen. Counsel
Dr. Joanne M. Donovan M.D., Ph.D.
Chief Medical Officer
Dr. Behrad Derakhshan Ph.D.
Chief Bus. Officer
Dr. Alan J. Russell Ph.D.
Co-Founder, Chief Scientific Officer & Director
Dr. Marc Semigran M.D.
Chief Devel. Officer
Dr. Kevin Koch Ph.D.
Pres, Chief Executive Officer & Director
EWTX's closing price is 82.15% higher than its 52-week low of $14.90 where as its distance from 52-week high of $38.12 is -28.8%.
Number of EWTX employees currently stands at 108.
Official Website of EWTX is: https://www.edgewisetx.com
EWTX could be contacted at phone 303 735 8373 and can also be accessed through its website. EWTX operates from 3415 Colorado Avenue, Boulder, CO 80303, United States.
EWTX stock volume for the day was 1.16M shares. The average number of EWTX shares traded daily for last 3 months was 802.38K.
The market value of EWTX currently stands at $2.57B with its latest stock price at $27.14 and 94.69M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com